Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Rockx

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Acta Neuropathologica Communications|September 4, 2022
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variantsLisa Bauer, Melanie Rissmann, Feline F W Benavides, et al.
Plos Pathogens|October 17, 2013
Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibodyKai Xu, Barry Rockx, Yihu Xie, et al.
Plos Pathogens|January 22, 2025
A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studiesMelanie Rissmann, Danny Noack, Thomas M Spliethof, et al.
Emerging Microbes & Infections|July 5, 2022
Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamstersMelanie Rissmann, Danny Noack, Debby van Riel, et al.
Journal of Virology|January 29, 2010
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signalingMaudry Laurent-Rolle, Elena F Boer, Kirk J Lubick, et al.
Science Translational Medicine|October 21, 2011
A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challengeKatharine N Bossart, Thomas W Geisbert, Heinz Feldmann, et al.
One Health (Amsterdam, Netherlands)|August 30, 2021
Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization testCarmen W E Embregts, Babs Verstrepen, Jan A M Langermans, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Science (New York, N.Y.)|February 18, 2021
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferretsRory D de Vries, Katharina S Schmitz, Francesca T Bovier, et al.
The Journal of Infectious Diseases|May 27, 2021
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster ModelBart L Haagmans, Danny Noack, Nisreen M A Okba, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Acta Neuropathologica Communications|September 4, 2022
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variantsLisa Bauer, Melanie Rissmann, Feline F W Benavides, et al.
Plos Pathogens|October 17, 2013
Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibodyKai Xu, Barry Rockx, Yihu Xie, et al.
Plos Pathogens|January 22, 2025
A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studiesMelanie Rissmann, Danny Noack, Thomas M Spliethof, et al.
Emerging Microbes & Infections|July 5, 2022
Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamstersMelanie Rissmann, Danny Noack, Debby van Riel, et al.
Journal of Virology|January 29, 2010
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signalingMaudry Laurent-Rolle, Elena F Boer, Kirk J Lubick, et al.
Science Translational Medicine|October 21, 2011
A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challengeKatharine N Bossart, Thomas W Geisbert, Heinz Feldmann, et al.
One Health (Amsterdam, Netherlands)|August 30, 2021
Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization testCarmen W E Embregts, Babs Verstrepen, Jan A M Langermans, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Science (New York, N.Y.)|February 18, 2021
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferretsRory D de Vries, Katharina S Schmitz, Francesca T Bovier, et al.
The Journal of Infectious Diseases|May 27, 2021
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster ModelBart L Haagmans, Danny Noack, Nisreen M A Okba, et al.
Pageof 12